
Journal of Medicinal Chemistry p. 119 - 127 (1989)
Update date:2022-07-29
Topics:
Anderson, Wayne K.
Bhattacharjee, Debkumar
Houston, D. Michael
A series of bis(carbamate) derivatives of 1,2-substituted 4,5-bis(hydroxymethyl)imidazoles were prepared and evaluated against murine P388 lymphocytic leukemia.Electron-withdrawing substituents at either N-1 or C-2 gave rise to inactive compounds.However, electron-donating substituents gave active compounds and the 2-(methylthio)-1-methyl derivative 2i (carmethizole), as the bis(N-methylcarbamate), was found to be very active.The derivative 2i, referred to by the name carmethizole, was also shown to be active against the MX-1 mammary xenograft, the human amelanotic melanoma cell line (LOX) xenograft, the M5076 sarcoma, and L1210 lymphocytic leukemia.The solution stability, water solubility, pKa, and log P of carmethizole are also reported.
View MoreContact:+49-9398-993127
Address:Untertorstr. 27
Anhui Asahikasei Chemical Co., Ltd
Contact:86-551-4259770
Address:No. 88 Linquan Road Hefei Anhui China
Jiangxi Dongxu Chemical Science & Technology Co.,Ltd
Contact:+86-791-86899381
Address:Nanchang, Jiangxi, China
Zhuhai Rundu Pharmaceutical co.,Ltd
Contact:+86-756-7630755
Address:No.6,North Airport Road,Sanzao Town,Jinwan District
Liaoning Yufeng Chemical Co.,Ltd.
Contact:86-0419-3418888
Address:The metallurgical industrial zone,shoushan town, Liaoyang, Liaoning, China
Doi:10.1055/s-1988-27551
(1988)Doi:10.1002/hlca.200800410
(2009)Doi:10.1016/j.tetlet.2009.04.060
(2009)Doi:10.1021/ol901096d
(2009)Doi:10.1016/j.jorganchem.2008.04.030
(2008)Doi:10.1016/j.tetlet.2009.04.102
(2009)